Clinical use of serum and urine bone markers in the management of osteoporosis

By Srivastava Apurva K.   Vliet Elizabeth L.   Lewiecki E. Michael   Maricic Michael   Abdelmalek Alex   Gluck Oscar   Baylink David J.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1015-1026

Informa Healthcare

Access to resources Recommend Favorite

Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis

By Vasikaran Samuel  

Critical Reviews in Clinical Laboratory Sciences, Vol. 45, Iss. 2, 2008-03 ,pp. : 221-258

Informa Healthcare

Access to resources Recommend Favorite

The effect of PTH(1–84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial

By Quesada-Gómez J.   Muschitz C.   Gómez-Reino J.   Greisen H.   Andersen H.   Dimai H.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2529-2537

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical markers of bone turnover

By Carey John   Licata Angelo   Delaney Miriam  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 3, 2006-09 ,pp. : 197-211

Humana Press, Inc

Access to resources Recommend Favorite

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

By Vasikaran S.   Eastell R.   Bruyère O.   Foldes A.   Garnero P.   Griesmacher A.   McClung M.   Morris H.   Silverman S.   Trenti T.   Wahl D.   Cooper C.   Kanis J.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 391-420

Springer Publishing Company

Access to resources Recommend Favorite